Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 3:55 PM
Ignite Modification Date:
2025-12-24 @ 3:55 PM
NCT ID:
NCT00911092
Eligibility Criteria:
Inclusion Criteria:
* Invasive esophageal carcinoma at any stage (all T, N0 or N1, M0 or M1a), histologically proven
* Treated by exclusive concomitant radiochemotherapy
* Written informed consent
Exclusion Criteria:
* Presence of a second uncontrolled cancer
* Metastatic carcinoma
* Metastatic disease, except cervical lymphnodes... (M1a)
* In situ carcinoma
* Eso-gastric junction cancer (Siewert II ou III)
* Inclusion in a clinical trial with an experimental drug during the study and until 15 weeks after the end of radiotherapy)
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00911092
Study Brief:
Protocol Section:
NCT00911092